Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PFE - Arcutis Biotherapeutics Starts U.S. IPO Process

PFE - Arcutis Biotherapeutics Starts U.S. IPO Process

Pfizer Inc.

Quick Take

Arcutis Biotherapeutics (ARQT) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement.

The company is advancing a pipeline of drug treatment candidates for various chronic skin conditions.

ARQT is in Phase 3 trials for its lead candidate and expects topline data readout in 2021 for its most advanced programs.

I’ll provide an update when we learn more about the IPO’s valuation and pricing assumptions.

Company & Technology

Westlake Village, California-based Arcutis was founded to develop treatment for psoriasis and dermatitis

Read more ...
Stock Information
Company Name: Pfizer Inc.
Stock Symbol: PFE
Market: NYSE
Website: pfizer.com
Menu
PFE PFE Quote PFE Short PFE News PFE Articles PFE Message Board
Get PFE Alerts

News, Short Squeeze, Breakout and More Instantly...